Ashley JD - RPHM Old Chief Officer
| RPHMDelisted Stock | USD 18.20 1.40 8.33% |
Insider
Ashley JD is Chief Officer of RPHM Old
| Age | 52 |
| Phone | 858 283 0280 |
| Web | https://reneopharma.com |
RPHM Old Management Efficiency
The company has return on total asset (ROA) of (0.3372) % which means that it has lost $0.3372 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.54) %, meaning that it created substantial loss on money invested by shareholders. RPHM Old's management efficiency ratios could be used to measure how well RPHM Old manages its routine affairs as well as how well it operates its assets and liabilities.RPHM Old currently holds 973 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. RPHM Old has a current ratio of 15.52, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about RPHM Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Igor MD | Celcuity LLC | N/A | |
| Chulani Karunatilake | Werewolf Therapeutics | 65 | |
| Ying Huang | Legend Biotech Corp | 52 | |
| Timothy CPA | Werewolf Therapeutics | 67 | |
| Sharen Pyatetskaya | Hepion Pharmaceuticals | ||
| David Liu | Prime Medicine, Common | N/A | |
| MBA MD | Cullinan Oncology LLC | 51 | |
| Christopher Hite | Royalty Pharma Plc | 57 | |
| Mark Dmytruk | Ginkgo Bioworks Holdings | 54 | |
| Johanna FriedlNaderer | Vir Biotechnology | 56 | |
| Kelly Schick | C4 Therapeutics | 45 | |
| DSc MSE | Immix Biopharma | 75 | |
| Stephen MD | Hepion Pharmaceuticals | N/A | |
| Eric Lindquist | Celcuity LLC | N/A | |
| BCh BM | Kronos Bio | 40 | |
| Stewart Fisher | C4 Therapeutics | 57 | |
| Ellen MBA | Werewolf Therapeutics | 49 | |
| Lori CPA | Legend Biotech Corp | 53 | |
| Andrew Hirsch | C4 Therapeutics | 53 | |
| Marie Fallon | Ginkgo Bioworks Holdings | N/A | |
| Divya Chari | Summit Therapeutics PLC | 57 | |
Management Performance
| Return On Equity | -0.54 | |||
| Return On Asset | -0.34 |
RPHM Old Leadership Team
Elected by the shareholders, the RPHM Old's board of directors comprises two types of representatives: RPHM Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RPHM. The board's role is to monitor RPHM Old's management team and ensure that shareholders' interests are well served. RPHM Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RPHM Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gregory Flesher, CEO President | ||
| Alejandro MD, Chief Officer | ||
| Ashley JD, Chief Officer | ||
| Wendy MBA, Consultant | ||
| Vineet Jindal, Consultant | ||
| Michael Cruse, Chief Officer | ||
| Jennifer Lam, Principal Officer | ||
| Lynn Purkins, Senior Development | ||
| Michael Grey, Founder Chairman |
RPHM Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is RPHM Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.54 | |||
| Return On Asset | -0.34 | |||
| Current Valuation | (15.01 M) | |||
| Shares Outstanding | 3.34 M | |||
| Shares Owned By Insiders | 5.19 % | |||
| Shares Owned By Institutions | 87.75 % | |||
| Number Of Shares Shorted | 3.4 M | |||
| Price To Book | 0.79 X | |||
| EBITDA | (82.23 M) | |||
| Net Income | (77.39 M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in RPHM Stock
If you are still planning to invest in RPHM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RPHM Old's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |